Patients at risk for preterm delivery are frequently administered both antenatal steroids for fetal maturation and magnesium sulfate for neuroprotection. In this study, we investigate whether steroids coadministered with magnesium sulfate preserve blood–brain barrier integrity in neuroinflammation. Human umbilical vein endothelial cells were grown in astroglial conditioned media in a 2-chamber cell culture apparatus. Treatment with tumor necrosis factor-α (TNF-α) or catalytically active recombinant matrix metalloproteinase 9 (MMP-9) simulated neuroinflammation. Membrane integrity was assessed by zona occludens 1 (ZO-1) immunoreactivity, permeability to fluorescently conjugated dextran, and transendothelial electrical resistance (TEER). The TNF-α and MMP-9 treatment increased the rate of dextran transit, decreased TEER, and decreased ZO-1 immunoreactivity at junctional interfaces. Dexamethasone pretreatment alone or in combination with 0.5 mmol/L magnesium sulfate preserved monolayer integrity after inflammatory insult. Magnesium sulfate alone was not protective. This study supports a possible interaction between steroids and magnesium in neuroprotection.
VolpeJJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009;8(1):110–124.
2.
Conde-AgudeloARomeroR. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009;200(6):595–609.
3.
MurataYItakuraAMatsuzawaKOkumuraAWakaiKMizutaniS. Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia. Brain Dev. 2005;27(1):17–21.
4.
WuYWColfordJMJr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA. 2000;284(11):1417–1424.
5.
GomezRRomeroRGhezziFYoonBHMazorMBerrySM. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998;179(1):194–202.
6.
YoonBHJunJKRomeroRAmniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997;177(1):19–26.
7.
YoonBHRomeroRParkJSFetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 2000;182(3):675–681.
8.
YoonBHParkCWChaiworapongsaT. Intrauterine infection and the development of cerebral palsy. BJOG. 2003;110(suppl 20):124–127.
9.
YoonBHRomeroRYangSHInterleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol. 1996;174(5):1433–1440.
10.
DeguchiKMizuguchiMTakashimaS. Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia. Pediatr Neurol. 1996;14(1):13–16.
11.
KadhimHTabarkiBDe PrezCSebireG. Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy?Acta Neuropathol. 2003;105(3):209–216.
12.
YoonBHRomeroRKimCJHigh expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol. 1997;177(2):406–411.
13.
McAdamsRMJuulSE. The role of cytokines and inflammatory cells in perinatal brain injury. Neurol Res Int. 2012;2012:561494.
14.
ZhangHAdwanikarHWerbZNoble-HaeussleinLJ. Matrix metalloproteinases and neurotrauma: evolving roles in injury and reparative processes. Neuroscientist. 2010;16(2):156–170.
15.
RomeroRChaiworapongsaTEspinozaJFetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol. 2002;187(5):1125–1130.
16.
Vadillo-OrtegaFHernandezAGonzalez-AvilaGBermejoLIwataKStraussJF, 3r. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol. 1996;174(4):1371–1376.
17.
WeissAGoldmanSShalevE. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci. 2007;12:649–659.
18.
Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA. 1995;273(5):413–418.
19.
BaudOFoix-L'HeliasLKaminskiMAntenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med. 1999;341(16):1190–1196.
20.
KentALomasFHurrionEDahlstromJE. Antenatal steroids may reduce adverse neurological outcome following chorioamnionitis: neurodevelopmental outcome and chorioamnionitis in premature infants. J Paediatr Child Health. 2005;41(4):186–190.
21.
American College of Obstetricians and Gynecologists Committee on Obstetric Practice; Society for Maternal-Fetal Medicine.Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol. 2010;115(3):669–671.
22.
DoyleLWCrowtherCAMiddletonPMarretSRouseD. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;(1):CD004661.
CrowtherCAHillerJEDoyleLWHaslamRR. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003;290(20):2669–2676.
25.
MarretSMarpeauLZupan-SimunekVMagnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*. BJOG. 2007;114(3):310–318.
26.
RouseDJHirtzDGThomEA randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008;359(9):895–905.
27.
BergerIPelegOOfek-ShlomaiN. Inflammation and early brain injury in term and preterm infants. Isr Med Assoc J. 2012;14(5):318–323.
28.
DammannOLevitonA. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 1997;42(1):1–8.
29.
BaudOEmilieDPelletierEAmniotic fluid concentrations of interleukin-1beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: histological associations and neonatal outcome. Br J Obstet Gynaecol. 1999;106(1):72–77.
30.
ProcianoyRSSilveiraRC. Association between high cytokine levels with white matter injury in preterm infants with sepsis. Pediatr Crit Care Med. 2012;13(2):183–187.
31.
DollnerHVattenLHalgunsetJRahimipoorSAustgulenR. Histologic chorioamnionitis and umbilical serum levels of pro-inflammatory cytokines and cytokine inhibitors. BJOG. 2002;109(5):534–539.
32.
ShalakLFLaptookARJafriHSRamiloOPerlmanJM. Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics. 2002;110(4):673–680.
33.
DeliMAAbrahamCSKataokaYNiwaM. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol. 2005;25(1):59–127.
34.
KacimiRGiffardRGYenariMA. Endotoxin-activated microglia injure brain derived endothelial cells via NF-kappaB, JAK-STAT and JNK stress kinase pathways. J Inflamm (Lond). 2011;8:7.
35.
HurstRDFritzIB. Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood-brain barrier. J Cell Physiol. 1996;167(1):81–88.
36.
RochelsonBDowlingOSchwartzNMetzCN. Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway. J Reprod Immunol. 2007;73(2):101–107.
37.
TanKHDobbieMSFelixRABarrandMAHurstRD. A comparison of the induction of immortalized endothelial cell impermeability by astrocytes. Neuroreport. 2001;12(7):1329–1334.
38.
CecchelliRDehouckBDescampsLIn vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev. 1999;36(2-3):165–178.
39.
Burke-GaffneyAKeenanAK. Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1 alpha/beta, tumor necrosis factor-alpha and interferon-gamma. Immunopharmacology. 1993;25(1):1–9.
40.
ForsterCKahlesTKietzSDrenckhahnD. Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. J Physiol. 2007;580(pt 3):937–949.
41.
KreamJMulaySFukushimaDKSolomonS. Determination of plasma dexamethasone in the mother and the newborn after administration of the hormone in a clinical trial. J Clin Endocrinol Metab. 1983;56(1):127–133.
42.
RouseDJ. Magnesium sulfate (MgSO4) dose and timing, and umbilical cord Mg++ concentration: relationship to cerebral palsy (CP). Am J Obstet Gynecol. 2008;199(6):S46.
43.
JohnsonLHMappDCRouseDJAssociation of cord blood magnesium concentration and neonatal resuscitation. J Pediatr. 2012;160(4):573–577 e571.
SchneiderCARasbandWSEliceiriKW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–675.
46.
Arganda-CarrerasIFernandez-GonzalezRMunoz-BarrutiaA, Ortiz-De-Solorzano C. 3D reconstruction of histological sections: application to mammary gland tissue. Microsc Res Tech. 2010;73(11):1019–1029.
47.
DolinskyBMIppolitoDLTinnemoreDStallingsJDZeligCM,Napolitano PG. The effect of magnesium sulfate on the activity of matrix metalloproteinase-9 in fetal cord plasma and human umbilical vein endothelial cells. Am J Obstet Gynecol. 2010;203(4):371 e371–375.
48.
PrydePGMittendorfR. Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose. Obstet Gynecol. 2009;114(3):669–673.
49.
AgarwalRChiswickMLRimmerSAntenatal steroids are associated with a reduction in the incidence of cerebral white matter lesions in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2002;86(2):F96–F101.
50.
KaurCLingEA. Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells. Prog Neurobiol. 2009;87(4):264–280.
51.
GrosseteteMPhelpsJArkoLYonasHRosenbergGA. Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury. Neurosurgery. 2009;65(4):702–708.
52.
BazzoniGDejanaE. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004;84(3):869–901.
53.
GrabbPAGilbertMR. Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier. J Neurosurg. 1995;82(6):1053–1058.
54.
DittmarMSPetermichlWSchlachetzkiFGrafBMGruberM. Isoflurane induces endothelial apoptosis of the post-hypoxic blood-brain barrier in a transdifferentiated human umbilical vein endothelial cell model. PLoS One. 2012;7(6):e38260.
55.
RaubTJKuentzelSLSawadaGA. Permeability of bovine brain microvessel endothelial cells in vitro: barrier tightening by a factor released from astroglioma cells. Exp Cell Res. 1992;199(2):330–340.
56.
BrownJReadingSJJonesSCritical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest. 2000;80(1):37–45.
57.
KiesslingFKartenbeckJHallerC. Cell-cell contacts in the human cell line ECV304 exhibit both endothelial and epithelial characteristics. Cell Tissue Res. 1999;297(1):131–140.
58.
SudaKRothen-RutishauserBGunthertMWunderli-AllenspachH. Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell Dev Biol Anim. 2001;37(8):505–514.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
